Loading…
Tonix Pharmaceuticals Holding Corp. is projected to rise to $15.81 by 2027, a +21% move from its current price of $13.03. TNXP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $12.63 | $13.04 | $13.48 | +0.11% |
| Jul 13 | $12.47 | $13.06 | $13.67 | +0.23% |
| Jul 14 | $12.36 | $13.07 | $13.83 | +0.34% |
| Jul 15 | $12.27 | $13.09 | $13.97 | +0.46% |
| Jul 16 | $12.19 | $13.10 | $14.09 | +0.57% |
| Jul 17 | $12.11 | $13.12 | $14.21 | +0.69% |
| Jul 18 | $12.05 | $13.13 | $14.32 | +0.81% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.05 | $13.13 | $14.32 | +0.81% |
| Week 2 | $11.72 | $13.24 | $14.95 | +1.62% |
| Week 3 | $11.50 | $13.35 | $15.49 | +2.44% |
| Week 4 | $11.33 | $13.45 | $15.98 | +3.26% |
| Week 5 | $11.19 | $13.56 | $16.44 | +4.09% |
| Week 6 | $11.07 | $13.67 | $16.88 | +4.93% |
| Week 7 | $10.98 | $13.78 | $17.31 | +5.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tonix Pharmaceuticals Holding Corp. is a fully integrated biopharmaceutical company that develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia.
It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.
Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in Berkeley Heights, New Jersey.
Tonix Pharmaceuticals Holding Corp. (TNXP) is a healthcare stock with a current price of $13.22 and a market cap of $210.74M. It is ranked 3777 by market capitalization.
The forecast shows a price outlook across years, with a 2026 average price of $13.22, rising to 2027 average $16.11, 2028 average $18.06, and 2040 average $31.00, culminating in 2050 average $53.83.
The forecast also indicates bullish sentiment from 2027 onward, with a max price projected up to $108.77 in 2050 and an ROI of 307.2%.
A major floor 26.6% below — a decisive break under it would weaken the trend.
The nearest floor, 18.3% below — buyers have tended to step in here.
Price is pressing into resistance (1.5% away) — a breakout level to watch.
A major ceiling 23.4% above — clearing it would confirm fresh momentum.
Key TNXP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TNXP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.75 | Buy | $12.70 | Buy |
| MA 10 | $12.73 | Buy | $12.60 | Buy |
| MA 20 | $12.24 | Buy | $12.46 | Buy |
| MA 50 | $12.71 | Buy | $12.71 | Buy |
| MA 100 | $13.30 | Sell | $13.82 | Sell |
| MA 200 | $15.77 | Sell | $35.65 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.71 | Neutral |
| Stoch RSI (14) | 28.42 | Neutral |
| CCI (20) | 39.50 | Neutral |
| Williams %R (14) | -54.76 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 4.77 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 45.24 | Neutral |
| TRIX (15) | -0.01 | Sell |
| Awesome (5,34) | 0.57 | Buy |
| Ultimate (7,14,28) | 47.91 | Neutral |
| Momentum (10) | 0.55 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 12.85 | Buy |
| ADX (14) | 8.42 | Neutral |
| ATR (14) | 0.35 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 50.
The stock trades near the SMA50 of $12.84 and below the SMA200 of $16.52.
The 30-day range is $10.56-$16.55, with support at $10.65 and resistance at $15.74.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.65 | $13.03 | $20.19 | 0% | Neutral | |
| $12.36 | $15.81 | $21.52 | +21% | Bullish | |
| $13.29 | $17.58 | $24.98 | +35% | Bullish | |
| $13.00 | $17.69 | $25.99 | +36% | Bullish | |
| $12.04 | $16.80 | $25.39 | +29% | Bullish | |
| $12.58 | $17.96 | $27.80 | +38% | Bullish | |
| $12.98 | $18.94 | $29.96 | +45% | Bullish | |
| $15.60 | $23.23 | $37.47 | +78% | Bullish | |
| $17.41 | $26.42 | $43.40 | +103% | Bullish | |
| $16.44 | $25.42 | $42.47 | +95% | Bullish | |
| $20.37 | $34.29 | $61.41 | +163% | Bullish | |
| $31.63 | $61.89 | $122.55 | +375% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $10.65 | $13.03 | $16.23 | +0.00% |
| August 2026 | $12.09 | $14.34 | $17.53 | +10.07% |
| September 2026 | $12.09 | $14.47 | $17.91 | +0.86% |
| October 2026 | $12.23 | $14.74 | $18.45 | +1.87% |
| November 2026 | $12.83 | $15.55 | $19.66 | +5.55% |
| December 2026 | $12.99 | $15.84 | $20.19 | +1.84% |
Click any year to see its month-by-month TNXP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TNXP is projected to trade between $10.65 and $20.19, averaging $13.03 — a potential gain of 0% from today's $13.03. A consolidation phase looks the most probable path here.
Tonix Pharmaceuticals Holding Corp.'s 2027 outlook centres on $15.81, within a $12.36 to $21.52 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2028, TNXP could reach as high as $24.98, with a base case around $17.58 and support toward $13.29 — roughly +35% from $13.03. Buyers look set to stay in control over this stretch.
Expect TNXP to range from $13.00 to $25.99 through 2029. The $17.69 average target implies a +36% move from current prices. That is up +1% on the projected 2028 average. Momentum favours further upside here.
The TNXP price prediction for 2030 points to an average of $16.80 (low $12.04, high $25.39) — a potential gain of +29% on today's $13.03. Buyers look set to stay in control over this stretch.
In 2031, TNXP is projected to trade between $12.58 and $27.80, averaging $17.96 — a potential gain of +38% from today's $13.03. That is up +7% on the projected 2030 average. Momentum favours further upside here.
Tonix Pharmaceuticals Holding Corp.'s 2032 outlook centres on $18.94, within a $12.98 to $29.96 range. That is up +5% on the projected 2031 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TNXP could reach as high as $37.47, with a base case around $23.23 and support toward $15.60 — roughly +78% from $13.03. Momentum favours further upside here.
Expect TNXP to range from $17.41 to $43.40 through 2034. The $26.42 average target implies a +103% move from current prices. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TNXP price prediction for 2035 points to an average of $25.42 (low $16.44, high $42.47) — a potential gain of +95% on today's $13.03. Momentum favours further upside here.
In 2040, TNXP is projected to trade between $20.37 and $61.41, averaging $34.29 — a potential gain of +163% from today's $13.03. That is up +35% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Tonix Pharmaceuticals Holding Corp.'s 2050 outlook centres on $61.89, within a $31.63 to $122.55 range. That is up +80% on the projected 2040 average. That marks a +375% change versus current levels. Momentum favours further upside here.
Investing $1,000 in TNXP today (≈ 76.745971 TNXP) could be worth
$4,749.43
+$3,749.43 (+375%) by 2050 · US Dollar
Based on the average projected TNXP price of $61.89 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TNXPwould be worth at today's price.
$1,000 invested in TNXP on Jul 10, 2025 (≈ 23.607176 TNXP) would be worth
$307.6
-$692.4 (-69.2%) today · 0.31× · US Dollar
Based on a TNXP entry price of $42.36 vs. today's $13.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.34 | $1,055.92 | +5.6% |
| 1 month ago | $10.96 | $1,188.87 | +18.9% |
| 3 months ago | $12.48 | $1,044.07 | +4.4% |
| 6 months ago | $15.77 | $826.25 | -17.4% |
| 1 year ago | $42.36 | $307.6 | -69.2% |
| All time (5.0y) ago | $665,600 | $0.02 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TNXP forecast.
Our base-case forecast reaches $26.00 around 2034.
Implied market cap at $26.00: $414.46M
The multi-year forecast points to a bullish trajectory from 2027 onward. The expected averages include $16.11 in 2027, $18.06 in 2028, $17.47 in 2029, $16.33 in 2030, $17.45 in 2031, $17.48 in 2032, $21.64 in 2033, $25.05 in 2034, and $23.28 in 2035, $31.00 in 2040, and $53.83 in 2050.
The forecast provides bullish sentiment for 2027 (and later years) and shows rising max values, such as $56.49 in 2040 and $108.77 in 2050. ROI is projected at 21.9% in 2027, 36.6% in 2028, 32.1% in 2029, 23.6% in 2030, 32% in 2031, 32.2% in 2032, 63.7% in 2033, 89.5% in 2034, 76.1% in 2035, 134.5% in 2040, and 307.2% in 2050. The annualized volatility is 70%.
These figures are estimates and not guarantees.
Tap a question to reveal the answer.
2030 avg $16.33, min $11.57, max $24.98, ROI 23.6%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with higher average prices, e.g., 2027 avg $16.11 (ROI 21.9%), 2028 avg $18.06 (ROI 36.6%), and 2050 avg $53.83 (ROI 307.2%). These are estimates, not guarantees.
Yes—the 2040 forecast lists an average price of $31.00 and a max of $56.49, indicating $30 could be reached in the projection; other year maxes include $41.76 in 2034 and $24.98 in 2030.
RSI14 is 50; the price is near SMA50 ($12.84) and below SMA200 ($16.52); 30-day range is $10.56-$16.55; support is $10.65 and resistance is $15.74; sentiment is NEUTRAL; annualized volatility is 70%.
2050 avg $53.83, max $108.77; ROI 307.2%; sentiment BULLISH.
Tonix Pharmaceuticals Holding Corp. Community Discussion
0Share your Tonix Pharmaceuticals Holding Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.